1. Home
  2. KALA vs GWH Comparison

KALA vs GWH Comparison

Compare KALA & GWH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KALA
  • GWH
  • Stock Information
  • Founded
  • KALA 2009
  • GWH 2011
  • Country
  • KALA United States
  • GWH United States
  • Employees
  • KALA N/A
  • GWH N/A
  • Industry
  • KALA Biotechnology: Pharmaceutical Preparations
  • GWH Industrial Machinery/Components
  • Sector
  • KALA Health Care
  • GWH Miscellaneous
  • Exchange
  • KALA Nasdaq
  • GWH Nasdaq
  • Market Cap
  • KALA 26.2M
  • GWH 25.3M
  • IPO Year
  • KALA 2017
  • GWH N/A
  • Fundamental
  • Price
  • KALA $14.65
  • GWH $1.33
  • Analyst Decision
  • KALA Strong Buy
  • GWH Hold
  • Analyst Count
  • KALA 2
  • GWH 4
  • Target Price
  • KALA $13.50
  • GWH $2.67
  • AVG Volume (30 Days)
  • KALA 205.1K
  • GWH 187.4K
  • Earning Date
  • KALA 08-08-2025
  • GWH 08-14-2025
  • Dividend Yield
  • KALA N/A
  • GWH N/A
  • EPS Growth
  • KALA N/A
  • GWH N/A
  • EPS
  • KALA N/A
  • GWH N/A
  • Revenue
  • KALA N/A
  • GWH $6,166,000.00
  • Revenue This Year
  • KALA N/A
  • GWH $139.06
  • Revenue Next Year
  • KALA N/A
  • GWH $70.81
  • P/E Ratio
  • KALA N/A
  • GWH N/A
  • Revenue Growth
  • KALA N/A
  • GWH N/A
  • 52 Week Low
  • KALA $2.92
  • GWH $0.76
  • 52 Week High
  • KALA $15.80
  • GWH $10.12
  • Technical
  • Relative Strength Index (RSI)
  • KALA 82.92
  • GWH 37.96
  • Support Level
  • KALA $8.50
  • GWH $1.26
  • Resistance Level
  • KALA $15.80
  • GWH $1.69
  • Average True Range (ATR)
  • KALA 1.25
  • GWH 0.11
  • MACD
  • KALA 0.55
  • GWH -0.03
  • Stochastic Oscillator
  • KALA 86.77
  • GWH 17.44

About KALA KALA BIO Inc.

Kala Bio Inc is a biopharmaceutical company. The company is a clinical-stage biopharmaceutical company dedicated to researching, developing, and commercializing therapies for rare and severe eye diseases. KALA'smain product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.

About GWH ESS Tech Inc.

ESS Tech Inc is a long-duration energy storage company specializing in iron flow battery technology. The company design and produce long-duration batteries predominantly using earth-abundant materials.

Share on Social Networks: